Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema

BACKGROUND: Asymmetric dimethylarginine (ADMA)––the most potent endogenous NO-synthase inhibitor, has been regarded as mediator of endothelial dysfunction and oxidative stress. Considering experimental data, levels of ADMA and its structural isomer symmetric dimethylarginine (SDMA) might be elevated...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neuroinflammation
Autori principali: Worthmann, Hans, Li, Na, Martens-Lobenhoffer, Jens, Dirks, Meike, Schuppner, Ramona, Lichtinghagen, Ralf, Kielstein, Jan T., Raab, Peter, Lanfermann, Heinrich, Bode-Böger, Stefanie M., Weissenborn, Karin
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729507/
https://ncbi.nlm.nih.gov/pubmed/29237474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-1016-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi